Evidence map›Paper›PMID 30148701›Full record

ArticleJournal of medicinal food2018

Ginsenoside Rb1 Enhances Keratinocyte Migration by a Sphingosine-1-Phosphate-Dependent Mechanism.

Kyong-Oh Shin, Sung Jay Choe, Yoshikazu Uchida, Inyong Kim, Yoonhwa Jeong, Kyungho Park

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medicinal food, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.International journal of molecular sciences · 2022
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Ginsenoside Rb1 fromMolecules (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kyong-Oh Shin1 Department of Food Science and Nutrition, and Convergence Program of Material Science for Medicine and Pharmaceutics, Hallym University , Chuncheon, Korea.
Sung Jay Choe2 Department of Dermatology, Yonsei University Wonju College of Medicine , Wonju, Korea.
Yoshikazu Uchida3 Department of Dermatology, School of Medicine, University of California , San Francisco, San Francisco, California, USA.
Inyong Kim5 Research Center for Industrialization of Natural Nutraceuticals, Dankook University , Cheonan, Korea.
Yoonhwa Jeong5 Research Center for Industrialization of Natural Nutraceuticals, Dankook University , Cheonan, Korea.
Kyungho Park1 Department of Food Science and Nutrition, and Convergence Program of Material Science for Medicine and Pharmaceutics, Hallym University , Chuncheon, Korea.
Dankook University · KRHallym University · KRUniversity of California, San Francisco · USYonsei University · KR

Funding

S1P-Mediated Stimulation of Antimicrobial DefenseR01AR062025 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI HOLLERAN, WALTER M · 2012 to 2016
$1.6M
NIAMS NIH HHS R01 AR062025
6 · The paper itself

Abstract

The cutaneous wound healing process is tightly regulated by a range of cellular responses, including migration. Sphingosine-1-phosphate (S1P) is a signaling lipid produced in keratinocytes (KC) and it is known to stimulate skin wound repair through increased KC migration. Of the multifunctional triterpene ginsenosides, Rb1 enhances cutaneous wound healing process by increasing KC migration, but cellular mechanisms responsible for the Rb1-mediated increase in KC migration are largely unknown. Therefore, we hypothesized that, and assessed whether, Rb1 could stimulate KC migration through S1P-dependent mechanisms. Rb1 significantly increases S1P production by regulating the activity of metabolic conversion enzymes associated with S1P generation and degradation, sphingosine kinase 1 (SPHK1) and S1P lyase, respectively, in parallel with enhanced KC migration. However, blockade of ceramide to S1P metabolic conversion using a specific inhibitor of SPHK1 attenuated the expected Rb1-mediated increase in KC migration. Furthermore, a pan-S1P receptor inhibitor pertussis toxin significantly attenuated Rb1-induced stimulation of KC migration. Moreover, the Rb1-induced increases in KC migration required S1P receptor(s)-mediated activation of ERK1/2 and NF-κB, leading to production of key cutaneous migrating proteins, matrix metalloproteinase (MMP)-2 and MMP-9. Taken together, the results show that Rb1 stimulates KC migration through an S1P→S1P receptor(s)→ERK1/2→NF-κB→MMP-2/-9 pathway. This research revealed a previously unidentified cellular mechanism for Rb1 in enhancing KC migration and pointing to a new therapeutic approach to stimulate the cutaneous wound healing process.

Indexed as

Cell MovementCells, CulturedGinsenosidesHumansKeratinocytesLysophospholipidsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Membrane ProteinsMitogen-Activated Protein KinasesPanaxPhosphoric Monoester HydrolasesPhosphotransferases (Alcohol Group Acceptor)Plant ExtractsSignal TransductionSkinginsenoside Rb1GinsenosidesLysophospholipidsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Membrane ProteinsMitogen-Activated Protein KinasesPhosphoric Monoester HydrolasesPhosphotransferases (Alcohol Group Acceptor)Plant ExtractsSphingosinesphingosine 1-phosphatesphingosine-1-phosphate phosphataseSphingosine Kinasecutaneous wound healingginsenoside Rb1keratinocytemigrationS1P

Identifiers

PMID30148701
PMCPMC6913107
OpenAlexW2889381207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.